Department of Gastroenterology, Zhongshan Hospital Fudan University, Shanghai, China.
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.
Hepatic sinusoidal obstruction syndrome (HSOS) induced by a Chinese medicinal herb Tusanqi is increasingly being reported in recent years. The aim of the study was to investigate the possibility of using blood pyrrole-protein adducts test as a confirmatory diagnostic method.
Patients with HSOS according to international diagnostic criteria associated with Tusanqi from January 2006 to August 2010 in Zhongshan Hospital Fudan University were included and clinical features were collected. Pyrrole-protein adducts in blood sample were determined with ultra performance liquid chromatography-mass spectrometry (UPLC-MS) while pyrrolizidine alkaloids (PAs) in available herbal preparations were analyzed by high performance liquid chromatography-ultraviolet (HPLC-UV).
Five patients (age 41-72 years, median age 54 years, all women) were included. Ascites (5/5), jaundice (5/5) and hepatomegaly (4/5) were common manifestations. The imaging features were diffused, patchy hepatic enhancement, periportal edema and ascites. Pathology ascertained that blood flow was obstructive at the site of sinusoid. PAs (Seneionine and seneciphylline) were identified in all the three available herbal preparations ingested by the HSOS patients. Pyrrole-protein adducts were unequivocally found in all the five blood samples. Two patients recovered, two developed chronic illness and one died due to liver failure and hepatic encephalopathy.
The detection of blood pyrrole-protein adducts using a UPLC-MS approach is a specific, reliable, unambiguous and confirmatory test for HSOS induced by PA, and should be used together with the conventional HSOS clinical diagnostic criteria for the definitive diagnosis of PA-induced HSOS.
近年来,越来越多的报道称中药土三七引起肝窦阻塞综合征(HSOS)。本研究旨在探讨血液吡咯蛋白加合物检测作为一种确认性诊断方法的可能性。
纳入 2006 年 1 月至 2010 年 8 月在复旦大学中山医院按国际诊断标准诊断的与土三七相关的 HSOS 患者,并收集其临床特征。采用超高效液相色谱-质谱联用(UPLC-MS)法检测血样中的吡咯蛋白加合物,高效液相色谱-紫外(HPLC-UV)法分析可获得的草药制剂中的吡咯里西啶生物碱(PAs)。
共纳入 5 例患者(年龄 41-72 岁,中位年龄 54 岁,均为女性)。腹水(5/5)、黄疸(5/5)和肝肿大(4/5)是常见表现。影像学特征为弥漫性、斑片状肝增强、门静脉周围水肿和腹水。病理学证实窦状隙血流阻塞。HSOS 患者服用的 3 种草药制剂中均检出 PAs(千里光宁和千里光菲灵)。5 份血样中均明确检测到吡咯蛋白加合物。2 例患者痊愈,2 例发展为慢性疾病,1 例因肝功能衰竭和肝性脑病死亡。
采用 UPLC-MS 方法检测血液吡咯蛋白加合物是一种特异性、可靠、明确和可确认的 PA 引起的 HSOS 检测方法,应与传统的 HSOS 临床诊断标准一起用于 PA 引起的 HSOS 的明确诊断。